The present study examined the role of hepatocyte
NF-kappaB activation during
ischemia-reperfusion injury. Second, we evaluated the effects of ischemic
hypothermia on
NF-kappaB activation and liver injury. C57BL/6 mice underwent 90 min of partial hepatic
ischemia and up to 8 h of reperfusion. Body temperature was regulated during the ischemic period between 35 and 37 degrees C, 33 and 35 degrees C, 29 and 33 degrees C or unregulated, where temperature fell to <29 degrees C. Liver injury, as measured by serum
alanine aminotransferase as well as liver histopathology, was inversely proportional to regulated body temperature, with the unregulated group (<29 degrees C) being highly protected and the normothermic group (35-37 degrees C) displaying the greatest injury.
Inflammation, as measured by production of
TNF-alpha and liver recruitment of neutrophils, was greatest in the normothermic groups and lowest in the ischemic
hypothermia groups. Interestingly, hepatocyte
NF-kappaB activation was highest in the hypothermic group and least in the normothermic group. Paradoxically, degradation of IkappaB
proteins,
IkappaB-alpha and IkappaB-beta, was greatest in the normothermic group, suggesting an alternate
NF-kappaB regulatory mechanism during
ischemia-reperfusion injury. Subsequently, we found that
NF-kappaB p65
protein was increasingly degraded in normothermic versus hypothermic groups, and this degradation was specific for hepatocytes and was associated with decreased expression of the peptidyl-
prolyl isomerase Pin1. The data suggest that
NF-kappaB activation in hepatocytes is a protective response during
ischemia-reperfusion and can be augmented by ischemic
hypothermia. Furthermore, it appears that Pin1 promotes
NF-kappaB p65 protein stability such that decreased expression of Pin1 during
ischemia-reperfusion results in p65 degradation, reduced nuclear translocation of
NF-kappaB, and enhanced hepatocellular injury.